Is rehospitalization a measure of the efficacy of neuroleptics in the treatment of schizophrenia?

International Journal of Psychiatry in Clinical Practice

Volumn 2, Issue 4, 1998, Pages 275-278

  Bourin, M ^a,b,c   Jolliet, P ^a   Hery, P ^b   Guitton, B ^b  

^a Faculty of Medicine   (France)

^b CHU DE NANTES   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

Compliance; Hospitalization; Neuroleptics; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032410516     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509809115373     Document Type: Article

References (13)

1. Mason AS, Forrest I, Forrest F (1963) Adherence to maintenance therapy and rehopsitalization. Dis Nerv Syst 24: 103-104.
2. Raskin M, Dyson WL, Adams ME (1995) Depot neuroleptic therapy: clinical considerations. Can J Psyuchiatry 40: S5-S11.
3. Johnson DAW, Pasterski G, Ludlow JM (1983) The discontinuation of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatr Scand 67: 339-52.
4. Kasper JA, Hoge SK, Feucht-Haviar T et al (1997) Prospective study of patients' refusal of antipsychotic medication under a physician discretion review procedure. Am J Psychiatry 154: 483-9.
5. Bourin M, Venisse JL, Lecuyer F (1990) Résultats d'une enquête sur l'utilisation en psychiatrie des neuroleptiques à action prolongée. Encéphale 16: 363-9.
6. Gaebel W (1997) Towards the improvement of compliance: the significance of psychoeducation and new antipsychotics drugs. Int Clin Psychopharmacol 12: S37-S42.
7. Lin IF, Spiga R, Fortsch W (1979) Insight and adherence to medication in chronic schizophrenics. J Clin Psychiatry 40: 430-2.
8. McEvoy JP, Appelbaum PS, Apperson IJ (1989) Why must some schizophrenic patients be involuntarily committed? the role of insight. Compr Psychiatry 30: 13-17.
9. Buchanan RW, Carpenter WT (1996) Targeted maintenance treatment in schizophrenia. CNS Drugs 5: 240-5.
10. Bartel SJ, Drake RE (1988) Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 29: 467-83.
11. Carpentier WT Jr, Heinrichs DW, Wagman AML (1988) Deficit and non-deficit forms of schizophrenia: the concept. Am J Psychiatry 145: 578-83.
12. Lindström LH (1994) Long-term clinical and social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs. Acta Psychiatr Scand 89(suppl 380): 74-6.
13. Kane J, Aguglia E, Altamura AC et al (1998) Guidelines for depot antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol 8: 55-66.